Merck Expert Decries FDA Fosamax Report

Law360, New York (June 21, 2010, 7:05 PM EDT) -- A Merck & Co. endocrinologist told jurors Monday that a report by a U.S. Food and Drug Administration employee used to further the case of Fosamax product liability plaintiff Shirley Boles is "full of errors."

Under cross-examination, Anne de Papp testified in the U.S. District Court for the Southern District of New York that the report — which indicated poor results associated with the osteoporosis drug for certain purposes — "is wrong."

"The person who wrote this got this wrong," she said, when questioned about it...
To view the full article, register now.